We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Federal Court Upholds CollaGenex Classification As Antibiotic

Law360 (January 20, 2005, 12:00 AM EST) -- A federal court has upheld the U.S. Food and Drug Administration's classification of Periostat as an antibiotic drug, a decision that strips CollaGenex Pharmaceuticals Inc. of patent rights to the drug.

The drug maker vowed to seek “prompt injunctive relief” to protect its patent rights after the U.S. District Court for the District of Columbia upheld the FDA’s classification of Periostat as an antibiotic drug.

Under federal regulations, antibiotics are not entitled to the patent and exclusivity protection otherwise available under the Hatch Waxman amendments to...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.